Organizing Committee Member

Pall Thor Ingvarsson

Pall Thor Ingvarsson

Development Scientist
Novo Nordisk
Denmark

Biography

Pall Thor Ingvarsson completed his PhD in the field of pharmaceutics from University of Copenhagen in 2013 and later on his postdoctoral studies in collaboration with Statens Serum Insititut, Copenhagen Denmark. He has an extensive experience in the field of spray drying large molecules in academia and industry and has post his academic career worked as a scientist at GlaxoSmithKline in the UK and Novo Nordisk in Denmark.

Research Area

Pall Thor Ingvarsson completed his PhD in the field of pharmaceutics from University of Copenhagen in 2013 and later on his postdoctoral studies in collaboration with Statens Serum Insititut, Copenhagen Denmark. He has an extensive experience in the field of spray drying large molecules in academia and industry and has post his academic career worked as a scientist at GlaxoSmithKline in the UK and Novo Nordisk in Denmark.

Talk to Us

Speak directly to one of our conference representatives by calling.


+0044-2033180199

Mail Us

E-mail us your questions about the conference. We will respond to your questions.


contact@euroscicon.com

Contact Us

Have questions?
We'll be in touch within 24 hours.


Contact Us

Address

EuroSciCon Ltd
35 Ruddlesway,
Windsor, Berkshire,
SL4 5SF, UK

EuroSciCon Events are produced by Euroscicon Ltd

EuroSciCon, founded in 2001 is a UK based independent life science Events Company with predominantly business and academic client base. The key strategic objective of EuroSciCon is to communicate science and medical research between academia, clinical practice and the pharmaceutical industry. Most of its events are in Europe and London or live streamed. EuroSciCon expanded its operations to international in association with Meetings International, Singapore. All major meetings of EuroSciCon and Meetings International will issue Continued Professional Education (CPD), Continued Education (CE), Continued Medical Education (CME) Credits.